Adding value through innovation
BOEHRINGER INGELHEIM is a pharmaceutical company dedicated to research, manufacturing and the commercialisation of pharmaceutical products. As such, they aim to foster healthcare professional training and improve patient care quality.
Corporate social responsibility is a key element in Boehringer Ingelheim company culture. For this reason, they participate in social projects such as Making More Health, the Cronicidad: Horizonte 2025 (CH2025) platform, the Research Fund in Chronicity at IESE and now the DECIDE Chair at the Universitat Internacional de Catalunya (UIC).
This company looks after its workers and their families. Respect, equal opportunities and a good work-life balance are the basis of their mutual cooperation. What’s more, the company maintains a focus on environmental issues and sustainability in all the activities it undertakes.
The Boehringer Ingelheim group is among the top 20 companies in the pharmaceutical industry at a global level. With headquarters in Ingelheim, Germany, they work globally with 145 partners and more than 50,000 collaborators. Since it was founded in 1885, the family-run company has been committed to research, development, and the production of new products with high treatment value in terms of human and animal health.
We have been working in Spain since 1952, we have also made significant investments in two international production centres and a new corporate headquarters in Sant Cugat del Vallès. Over the past 60 years, we have evolved to become one of the top 15 pharmaceutical companies in Spain. The company has its national headquarters in Sant Cugat del Vallès (Barcelona), with over 1.600 workers.